期刊文献+

长期激素替代治疗对绝经后妇女身体成分和体脂分布的影响 被引量:2

Effects of Hormone Replacement Therapy on Body Composition and Fat Distribution in Postmenopausal Women
下载PDF
导出
摘要 目的:探讨长期激素替代治疗( H R T)对绝经后妇女身体成分和体脂分布的影响。方法:36 例健康意大利绝经后妇女分成两组: H R T 组,18 例;非 H R T 组(对照组),18 例。 H R T 组妇女每月经皮给予雌二醇(50 ng/d)和口服安宫黄体酮(10 m g/d),连续12 d。治疗时间3~10 年,平均3.9 年。身体测量包括身高、体重、胸围、臀围、腰围与臀围比率( W H R)。使用生物电阻抗法( B I M)测定身体成分(体脂% 及水分% )。日常活动情况按每天坐、立、行走、睡眠、体力活动时间(小时数)分成4 个等级。结果:除 H R T 组妇女腰围明显小于对照组妇女( P< 005)外,其它身体测量值、年龄及日常活动强度两组间均无明显差异。结论:长期雌孕激素联合治疗既不能预防也不能加重绝经后妇女体重、体脂的增加,但却可减少体脂从外周向中心的转移。 Objective: To evaluate the effects of hormone replacement therapy(HRT)on body composition and fot distribution in Italian postmenopausal women. Methods: Thirty six Italian postmenopausal women (48~65 years old) consisted of two groups: HRT group, 18 subjects and control group (non HRT), 18 subjects. The women in HRT group were treated for 3 to 10 years, average 3.9 years by transdermic estradial 50 ng/d and oral medroxyprogestrerone acetate (MPA) 10 mg/d for 12 consecutive days permaonth. Anthropometric measurements included height, weight, BNI, waist circumference, hip circumference and waist to hip ratio. The body composition (the percentage of body fot and water) estimated by means of bioelectrical impedance (BIM). Physical activities were classified to four levels. Results: We found that long term estrogen progesterone therapy prevented the increase in abdominal fat after menopause (P<0.05), whereas it did not have a statistically significant influence on total body fat mass. Conclusion: These results indicate that continuous daily estrogen and progesterone replacement therapy neither prevents nor increases postmenopausal weight gain and fat accumulation. However, it does minimize the shift from peripheral to central fat distribution.
作者 刘漪 G.Perrone
出处 《新疆医科大学学报》 CAS 1999年第1期9-10,共2页 Journal of Xinjiang Medical University
关键词 激素替代疗法 身体成分 体脂分布 绝经后 hormone replacement therapy (HRT) menopause body composition fot distribution
  • 相关文献

参考文献1

共引文献25

同被引文献19

  • 1袁鹰,鲁梅芳,王蓁.肥胖并子宫内膜癌病人腹部脂肪组织芳香化酶mRNA的表达[J].青岛大学医学院学报,2004,40(3):208-210. 被引量:5
  • 2鲁梅芳,袁鹰,阎胜利,王敏河,苏秀莲,董惠萍.绝经期后女性腹部脂肪组织芳香化酶mRNA表达的研究[J].天津医药,2004,32(10):610-612. 被引量:6
  • 3陆洁莉,赵咏桔.瘦素与神经性厌食[J].国外医学(内科学分册),2005,32(11):490-492. 被引量:5
  • 4岳军,杨业洲,陈廉.抵抗素与生殖[J].实用医院临床杂志,2006,3(3):87-89. 被引量:1
  • 5Hol st D, Grimaldi PA. New factors in the regulation of adipose differentiation and metabolism [ J ]. Curr Opin Lipidol, 2002, 13 : 241 - 245.
  • 6Greenberg AS, McDaniel MI. Identifying the links between obesity,insulin resistance and beta-cell function: Potential role of adipcytederived cytokines in the pathogenesis type 2 diabetes[ J]. Eur J Clin Invest,2002,13:24 - 34.
  • 7Simpson ER, Zhao Y, Agarwal VR, Michael MD, Bulun SE, et al. Aromatase expression in health and disease [ J ]. Rec Prog Horm Res, 1997,52 : 185 - 214.
  • 8Meldrum DR, Davidson BJ, Tataryn IV, Judd HL. Changes in circulating steroids with aging in postmenopausal women [ J ]. Obstet Gynecol, 1981,57:624.
  • 9McTeman PG, Anwar A, Eggo M C , et al. Gender differences in the regulation of P450 aromatase expression and activity in human adipose tissue[J].Int J Obes Relat Metab Disord,2000,2(7) :875 - 878.
  • 10Carey DG, Jenkins AB, Campell LV, et al. Abdominal fat and insulin resistance in normal and overweight women: direct measures reveal a strong relationship in subjects at both low and high risk of NIDDM[ J]. Diabetes, 1996,45:633 - 638.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部